OBJECTIVE: This article reviews recent literature on adults' quality of life following hematopoietic stem cell transplantation (HSCT). METHODS: We identified 22 prospective reports with at least 20 participants at baseline through a search of databases (Medline and PsycInfo) and handsearching of articles published from 2002 to October 2007. If longitudinal data were not available or were scarce for a particular topic or time point, cross-sectional studies were reviewed. RESULTS: Although physical, psychological, and social aspects of quality of life tend to improve during the years following transplantation, a significant proportion of HSCT survivors experience persistent anxiety and depressive symptoms, fatigue, sexual dysfunction, and fertility concerns. Despite ongoing treatment side effects, the majority of HSCT survivors resume their work, school, or household activities. CONCLUSION: We conclude that theory-driven research with larger samples is needed to identify subgroups of HSCT survivors with adjustment difficulties. Such research would examine survivors' evolving standards and definitions of quality of life to improve the accuracy and meaningfulness of assessment and incorporate biological, psychological, and contextual factors that may contribute to positive adjustment. (c) 2008 John Wiley & Sons, Ltd.
OBJECTIVE: This article reviews recent literature on adults' quality of life following hematopoietic stem cell transplantation (HSCT). METHODS: We identified 22 prospective reports with at least 20 participants at baseline through a search of databases (Medline and PsycInfo) and handsearching of articles published from 2002 to October 2007. If longitudinal data were not available or were scarce for a particular topic or time point, cross-sectional studies were reviewed. RESULTS: Although physical, psychological, and social aspects of quality of life tend to improve during the years following transplantation, a significant proportion of HSCT survivors experience persistent anxiety and depressive symptoms, fatigue, sexual dysfunction, and fertility concerns. Despite ongoing treatment side effects, the majority of HSCT survivors resume their work, school, or household activities. CONCLUSION: We conclude that theory-driven research with larger samples is needed to identify subgroups of HSCT survivors with adjustment difficulties. Such research would examine survivors' evolving standards and definitions of quality of life to improve the accuracy and meaningfulness of assessment and incorporate biological, psychological, and contextual factors that may contribute to positive adjustment. (c) 2008 John Wiley & Sons, Ltd.
Authors: Ian J Sadler; Paul B Jacobsen; Margaret Booth-Jones; Heather Belanger; Michael A Weitzner; Karen K Fields Journal: J Pain Symptom Manage Date: 2002-05 Impact factor: 3.612
Authors: M Díez-Campelo; J A Pérez-Simón; J R González-Porras; J M García-Cecilia; M Salinero; M D Caballero; M C Cañizo; E M Ocio; J F San Miguel Journal: Bone Marrow Transplant Date: 2004-10 Impact factor: 5.483
Authors: Margaret Bevans; Areej El-Jawahri; D Kathryn Tierney; Lori Wiener; William A Wood; Flora Hoodin; Erin E Kent; Paul B Jacobsen; Stephanie J Lee; Matthew M Hsieh; Ellen M Denzen; Karen L Syrjala Journal: Biol Blood Marrow Transplant Date: 2016-09-19 Impact factor: 5.742
Authors: Karen Clark; Paul Greene; Kate DuHamel; Matthew Loscalzo; Marcia Grant; Kim Glazier; William Redd Journal: J Cancer Educ Date: 2012-12 Impact factor: 2.037
Authors: Lisa Brice; Nicole Gilroy; Gemma Dyer; Masura Kabir; Matt Greenwood; Stephen Larsen; John Moore; John Kwan; Mark Hertzberg; Louisa Brown; Megan Hogg; Gillian Huang; Jeff Tan; Christopher Ward; David Gottlieb; Ian Kerridge Journal: Support Care Cancer Date: 2016-10-03 Impact factor: 3.603
Authors: A M J Braamse; B van Meijel; O Visser; P C Huijgens; A T F Beekman; J Dekker Journal: Bone Marrow Transplant Date: 2013-10-07 Impact factor: 5.483
Authors: Areej R El-Jawahri; Harry B Vandusen; Lara N Traeger; Joel N Fishbein; Tanya Keenan; Emily R Gallagher; Joseph A Greer; William F Pirl; Vicki A Jackson; Thomas R Spitzer; Yi-Bin A Chen; Jennifer S Temel Journal: Cancer Date: 2015-12-09 Impact factor: 6.860